Benjamin Turner

1.4k citations

42 papers · 933 indexed · 1 hit paper · h-index 14

Impact in

Pathology and Forensic Medicine top 2%
- Multiple Sclerosis Research Studies
- Systemic Sclerosis and Related Diseases
Neurology top 5%
- Peripheral Neuropathies and Disorders

Papers in ⓘ

Pathology and Forensic Medicine 24
- Multiple Sclerosis Research Studies 24
Rheumatology 11
- Rheumatoid Arthritis Research and Therapies 5
- Systemic Lupus Erythematosus Research 4

Co-authors: Klaus Schmierer (28 shared papers)Gavin Giovannoni (25 shared papers)Mónica Marta (20 shared papers)Sharmilee Gnanapavan (15 shared papers)Curtis Offiah (1 shared paper)David Baker (13 shared papers)Daniel R. Altmann (6 shared papers)Neil Roberts (1 shared paper)
Journals: Multiple Sclerosis and Related Disorders (8 papers)Neurology (5 papers)Multiple Sclerosis Journal (5 papers)Journal of Neurology Neurosurgery & Psychiatry (3 papers)Journal of Neurology (2 papers)
Partner nations: United Kingdom United States France

In The Last Decade

Benjamin Turner

39 papers receiving 916 citations

Hit Papers

align trajectories log scale

Is it time to target no evident disease activity (NEDA) in multiple sclerosis? 2015 · 275 citations

Peers

Countries citing papers authored by Benjamin Turner

Since Specialization

Citations

This map shows the geographic impact of Benjamin Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Turner more than expected).

Fields of papers citing papers by Benjamin Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Turner. The network helps show where Benjamin Turner may publish in the future.

Co-authors

The 25 scholars most cited alongside Benjamin Turner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benjamin Turner Line = papers co-authored together Benjamin Turner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Is it time to target no evident disease activity (NEDA) in multiple sclerosis? Multiple Sclerosis and Related Disorders ·Gavin Giovannoni, Benjamin Turner, Sharmilee Gnanapavan, Curtis Offiah, Klaus Schmierer, Mónica Marta Hit paper breakdown →	2015	275
2	No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine Neurology Neuroimmunology & Neuroinflammation ·Julia Pakpoor, Giulio Disanto, Daniel R. Altmann, Sue Pavitt, Benjamin Turner, Mónica Marta, Gunnar Juliusson, David Baker, Jeremy Chataway, Klaus Schmierer	2015	101
3	No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation Journal of Neurology ·Stephen Keddie, Ashok Adams, Andrew Kelso, Benjamin Turner, Klaus Schmierer, Sharmilee Gnanapavan, Andrea Malaspina, Gavin Giovannoni, Ian Basnett, Alastair J. Noyce	2018	71
4	Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis Journal of Neurology ·Benjamin Turner, Bruce Cree, Ludwig Kappos, Xavier Montalbán, Caroline Papeix, Jerry S. Wolinsky, Régine Buffels, Damian Fiore, Hideki Garren, Jian Han, Stephen L. Hauser	2019	59
5	C erebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years Multiple Sclerosis Journal ·Benjamin Turner, Xia Lin, Guillaume Calmon, Neil Roberts, Lance D. Blumhardt	2003	53
6	FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis? European Radiology ·Tom Campion, Rachel J. Smith, Daniel R. Altmann, Guilherme Camargo Brito, Benjamin Turner, Jane Evanson, Ilena George, Pascal Sati, Daniel S. Reich, Marc E. Miquel, Klaus Schmierer	2017	44
7	Neurosurgery and elderly: analysis through the years Neurosurgical Review ·Salvatore Chibbaro, Federico Di Rocco, O. Makiese, Giuseppe Mirone, M. Marsella, A.-C. Lukaszewicz, Éric Vicaut, Benjamin Turner, S. Hamdi, Toma Spiriev, P. Di Emidio, Romain Pirracchio, Didier Payen, Bernard George, Damien Bresson	2011	43
8	Switching patients at high risk of PML from natalizumab to another disease-modifying therapy Practical Neurology ·Gavin Giovannoni, Mónica Marta, Angharad Davis, Benjamin Turner, Sharmilee Gnanapavan, Klaus Schmierer	2016	41
9	Ethnicity and prevalence of multiple sclerosis in east London Multiple Sclerosis Journal ·Christo Albor, Timothy du Sautoy, Narmadha Kali Vanan, Benjamin Turner, Kambiz Boomla, Klaus Schmierer	2016	37
10	Protecting people with multiple sclerosis through vaccination Practical Neurology ·Saúl Reyes, Mary Ramsay, Shamez Ladhani, Gayatri Amirthalingam, Neena Singh, Carlos Cores, Joela Mathews, Jonathan Lambourne, Mónica Marta, Benjamin Turner, Sharmilee Gnanapavan, Ruth Dobson, Klaus Schmierer, Gavin Giovannoni	2020	36
11	New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer’s disease Brain ·Sourav Samanta, Firoz Akhter, Anuradha Roy, Doris Chen, Benjamin Turner, Yongfu Wang, Nicolina Clemente, Chunyu Wang, Russell H. Swerdlow, K.P. Battaile, Scott Lovell, Shi Fang Yan, Shirley ShiDu Yan	2023	29
12	A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study Multiple Sclerosis and Related Disorders ·Julian Gold, Mónica Marta, Ute‐Christiane Meier, Tove Christensen, David Miller, Daniel R. Altmann, David W. Holden, Lucia Bianchi, Rocco Adiutori, David MacManus, Tarek Yousry, Klaus Schmierer, Benjamin Turner, Gavin Giovannoni	2018	26
13	CSF neurofilament light chain testing as an aid to determine treatment strategies in MS Neurology Neuroimmunology & Neuroinflammation ·Saúl Reyes, Ide Smets, David W. Holden, Karina Carrillo-Loza, Tatiana Christmas, Lucia Bianchi, Francesca Ammoscato, Benjamin Turner, Mónica Marta, Klaus Schmierer, Gavin Giovannoni, Sharmilee Gnanapavan	2020	15
14	Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis Annals of Clinical and Translational Neurology ·César Álvarez-González, Ashok Adams, Joela Mathews, Benjamin Turner, Gavin Giovannoni, David Baker, Klaus Schmierer	2017	15
15	Eosinophilia, meningitis and pulmonary nodules in a young woman Thorax ·Paul Pfeffer, Arjune Sen, Sourav Das, Michael Sheaff, Anusha Sivaramakrishnan, David E. Simcock, Benjamin Turner	2010	11
16	Validation of an environmentally-friendly and affordable cardboard 9-hole peg test Multiple Sclerosis and Related Disorders ·Nicolas Dubuisson, Angelika Bauer, Mark G. Buckley, Rich Gilbert, Adam Paterson, Mónica Marta, Sharmilee Gnanapavan, Benjamin Turner, David Baker, Gavin Giovannoni, Klaus Schmierer, Alison Thomson	2017	10
17	Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies Multiple Sclerosis and Related Disorders ·Zhifeng Mao, César Álvarez-González, Kimberley Allen‐Philbey, Stefania De Trane, Özlem Kayım Yıldız, Tom Campion, Ashok Adams, Benjamin Turner, Mónica Marta, Sharmilee Gnanapavan, Maria Espasandin, Joela Mathews, Gavin Giovannoni, David Baker, Klaus Schmierer	2018	9
18	Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings? Multiple Sclerosis Journal - Experimental Translational and Clinical ·Zhifeng Mao, César Álvarez-González, Stefania De Trane, Özlem Yildiz, Christo Albor, Gabriel Doctor, Derek Soon, George Pepper, Benjamin Turner, Mónica Marta, Joela Mathews, Gavin Giovannoni, David Baker, Klaus Schmierer	2018	7
19	Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosis Multiple Sclerosis and Related Disorders ·Saúl Reyes, Sebastián Suárez, Kimberley Allen‐Philbey, Özlem Kayım Yıldız, Joela Mathews, Grace Anjorin, F.Kathryn Edwards, Cherry Jain, Benjamin Turner, Mónica Marta, Sharmilee Gnanapavan, Klaus Schmierer, Gavin Giovannoni	2020	6
20	Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosis Therapeutic Advances in Neurological Disorders ·Kimberley Allen‐Philbey, Stefania De Trane, Amy MacDougall, Ashok Adams, Lucia Bianchi, Thomas Campion, Gavin Giovannoni, Sharmilee Gnanapavan, David W. Holden, Mónica Marta, Joela Mathews, Benjamin Turner, David Baker, Klaus Schmierer	2023	5

About Benjamin Turner

Benjamin Turner is a scholar working on Pathology and Forensic Medicine, Rheumatology, Neurology, Oncology and Genetics, having authored 42 papers that have together received 933 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (24 papers), Chronic Lymphocytic Leukemia Research (7 papers), Polyomavirus and related diseases (7 papers), Peripheral Neuropathies and Disorders (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (687 citations), Neurology (298 citations), Rheumatology (195 citations), Developmental Neuroscience (39 citations) and Oncology (239 citations). Benjamin Turner has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Klaus Schmierer, Gavin Giovannoni, Mónica Marta, Sharmilee Gnanapavan, Curtis Offiah, David Baker, Daniel R. Altmann, Neil Roberts, Lance D. Blumhardt and Xia Lin. Their work appears in journals such as Multiple Sclerosis and Related Disorders, Neurology, Multiple Sclerosis Journal, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact